Pharmacokinetics of the Meropenem Component of Meropenem‐Vaborbactam in the Treatment of KPC ‐Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric Patient

β-lactam Therapeutic Drug Management in the PICU*

(2018) Jeffrey J. Cies et al.   CRITICAL CARE MEDICINE

Ceftaroline for Suspected or Confirmed Invasive Methicillin-Resistant Staphylococcus aureus

(2018) Jeffrey J. Cies et al.   Pediatric Critical Care Medicine

Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects

(2015) Eric Wenzler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem-Resistant Enterobacteriaceae Infections in Children

(2015) Kathleen Chiotos et al.   Current Infectious Disease Reports

The Global Challenge of Carbapenem-Resistant Enterobacteriaceae in Transplant Recipients and Patients With Hematologic Malignancies

(2014) M. J. Satlin et al.   CLINICAL INFECTIOUS DISEASES

Carbapenem-Resistant Enterobacteriaceae: An Emerging Problem in Children

(2012) L. K. Logan   CLINICAL INFECTIOUS DISEASES

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

(2011) N. Gupta et al.   CLINICAL INFECTIOUS DISEASES

Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

(2009) Abraham Borer et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Optimizing bactericidal exposure for β-lactams using prolonged and continuous infusions in the pediatric population

(2009) Joshua D. Courter et al.   PEDIATRIC BLOOD & CANCER